Transplanted human amniotic membrane-derived mesenchymal stem cells ameliorate carbon tetrachloride-induced liver cirrhosis in mouse

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Zhang, DingGuo ^a   Jiang, MinYue ^a   Miao, Deng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; SUPEROXIDE DISMUTASE;

AMNION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD ANALYSIS; CELL ACTIVATION; CELL AGING; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; ENGRAFTMENT; ENZYME ACTIVITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER REGENERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; STELLATE CELL; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; EVALUATION; EXPERIMENTAL LIVER CIRRHOSIS; FEMALE; INTOXICATION; LIVER CELL; MESENCHYMAL STEM CELL; PATHOLOGY; PHYSIOLOGY;

ANIMALIA; MUS;

AMNION; ANIMALS; CARBON TETRACHLORIDE; CARBON TETRACHLORIDE POISONING; CELLS, CULTURED; FEMALE; HEPATOCYTES; HUMANS; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER REGENERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL;

EID: 79951527488     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016789     Document Type: Article

References (48)

1. Goodman ZD, (2007) Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 47: 598-607.
2. Kisseleva T, Gigante E, Brenner DA, (2010) Recent advances in liver stem cell therapy. Curr Opin Gastroenterol 26: 395-402.
3. Huang YW, Hu JT, Yang SS, (2010) Complications of alcoholic liver cirrhosis: Active assessment by endoscopy and sonography. Hepatology.
4. Silveira MG, Brunt EM, Heathcote J, Gores GJ, Lindor KD, et al. (2010) American Association for the Study of Liver Diseases endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosis. Hepatology 52: 349-359.
5. Park JK, Ki MR, Lee HR, Hong IH, Ji AR, et al. (2010) Vitamin C deficiency attenuates liver fibrosis by way of up-regulated peroxisome proliferator-activated receptor-gamma expression in senescence marker protein 30 knockout mice. Hepatology 51: 1766-1777.
6. Muhanna N, Tair LA, Doron S, Amer J, Azzeh M, et al. (2010) Amelioration of hepatic fibrosis by NK cell activation. Gut.
7. Neuberger J, Gimson A, Davies M, Akyol M, O'Grady J, et al. (2008) Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 57: 252-257.
8. Vizzutti F, Arena U, Nobili V, Tarquini R, Trappoliere M, et al. (2009) Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease. Ann Hepatol 8: 89-94.
9. Zatonski WA, Sulkowska U, Manczuk M, Rehm J, Boffetta P, et al. (2010) Liver Cirrhosis Mortality in Europe, with Special Attention to Central and Eastern Europe. Eur Addict Res 16: 193-201.
10. Morrison DS, Boyd AA, Richardson T, (2006) Liver cirrhosis mortality rates in Britain. Lancet 367: 1899; author reply 1900.
11. Chernykh ER, Starostina NM, Paltsev AI, Leplina OY, Shevela EY, et al. (2007) Autologous bone marrow cells in the treatment of cirrhosis of the liver. Bull Exp Biol Med 144: 640-645.
12. Pai M, Zacharoulis D, Milicevic MN, Helmy S, Jiao LR, et al. (2008) Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 103: 1952-1958.
13. Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, et al. (2007) Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 13: 3359-3363.
14. Salama H, Zekri AR, Zern M, Bahnassy A, Loutfy S, et al. (2010) Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases. Cell Transplant.
15. Houlihan DD, Newsome PN, (2008) Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 135: 438-450.
16. Khan AA, Shaik MV, Parveen N, Rajendraprasad A, Aleem MA, et al. (2010) Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. Cell Transplant 19: 409-418.
17. Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, et al. (2004) Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78: 1439-1448.
18. Zhao P, Ise H, Hongo M, Ota M, Konishi I, et al. (2005) Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 79: 528-535.
19. Tsuji H, Miyoshi S, Ikegami Y, Hida N, Asada H, et al. (2010) Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res 106: 1613-1623.
20. Marcus AJ, Coyne TM, Rauch J, Woodbury D, Black IB, (2008) Isolation, characterization, and differentiation of stem cells derived from the rat amniotic membrane. Differentiation 76: 130-144.
21. Cargnoni A, Gibelli L, Tosini A, Signoroni PB, Nassuato C, et al. (2009) Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant 18: 405-422.
22. Jeong WI, Park O, Radaeva S, Gao B, (2006) STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology 44: 1441-1451.
23. Moriya K, Yoshikawa M, Saito K, Ouji Y, Nishiofuku M, et al. (2007) Embryonic stem cells develop into hepatocytes after intrasplenic transplantation in CCl4-treated mice. World J Gastroenterol 13: 866-873.
24. Cai J, Ito M, Nagata H, Westerman KA, Lafleur D, et al. (2002) Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes. Hepatology 36: 386-394.
25. Nieto N, Cederbaum AI, (2005) S-adenosylmethionine blocks collagen I production by preventing transforming growth factor-beta induction of the COL1A2 promoter. J Biol Chem 280: 30963-30974.
26. Yang YJ, Qian HY, Huang J, Geng YJ, Gao RL, et al. (2008) Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. Eur Heart J 29: 1578-1590.
27. Kim H, Park JS, Choi YJ, Kim MO, Huh YH, et al. (2009) Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy. Stem Cells 27: 1686-1696.
28. Gao F, He T, Wang H, Yu S, Yi D, et al. (2007) A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. Can J Cardiol 23: 891-898.
29. Yokoi Y, Namihisa T, Matsuzaki K, Miyazaki A, Yamaguchi Y, (1988) Distribution of Ito cells in experimental hepatic fibrosis. Liver 8: 48-52.
30. Roderfeld M, Rath T, Voswinckel R, Dierkes C, Dietrich H, et al. (2010) Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice. Hepatology 51: 267-276.
31. Paik YH, Kim JK, Lee JI, Kang SH, Kim DY, et al. (2009) Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats. Gut 58: 1517-1527.
32. Carotti S, Morini S, Corradini SG, Burza MA, Molinaro A, et al. (2008) Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C. Liver Transpl 14: 806-814.
33. Salguero Palacios R, Roderfeld M, Hemmann S, Rath T, Atanasova S, et al. (2008) Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice. Lab Invest 88: 1192-1203.
34. Wu J, Danielsson A, Zern MA, (1999) Toxicity of hepatotoxins: new insights into mechanisms and therapy. Expert Opin Investig Drugs 8: 585-607.
35. Takehara T, Tatsumi T, Suzuki T, Rucker EB 3rd, Hennighausen L, et al. (2004) Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. Gastroenterology 127: 1189-1197.
36. Watanabe A, Hashmi A, Gomes DA, Town T, Badou A, et al. (2007) Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 46: 1509-1518.
37. Morita M, Watanabe Y, Akaike T, (1995) Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hepatocytes. Hepatology 21: 1585-1593.
38. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, et al. (1999) Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 5: 226-230.
39. Wiemann SU, Satyanarayana A, Tsahuridu M, Tillmann HL, Zender L, et al. (2002) Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J 16: 935-942.
40. Lefkowitch JH, (2008) Hepatobiliary pathology. Curr Opin Gastroenterol 24: 269-277.
41. Trak-Smayra V, Contreras J, Dondero F, Durand F, Dubois S, et al. (2004) Role of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV) recurrence after liver transplantation. Transplantation 77: 1755-1760.
42. Alani RM, Young AZ, Shifflett CB, (2001) Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc Natl Acad Sci U S A 98: 7812-7816.
43. Roninson IB, (2002) Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 179: 1-14.
44. Autiero I, Costantini S, Colonna G, (2009) Human sirt-1: molecular modeling and structure-function relationships of an unordered protein. PLoS One 4: e7350.
45. Aksoy P, Escande C, White TA, Thompson M, Soares S, et al. (2006) Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38. Biochem Biophys Res Commun 349: 353-359.
46. Scalera F, Fulge B, Martens-Lobenhoffer J, Heimburg A, Bode-Boger SM, (2009) Red wine decreases asymmetric dimethylarginine via SIRT1 induction in human endothelial cells. Biochem Biophys Res Commun 390: 703-709.
47. Beckman KB, Ames BN, (1998) The free radical theory of aging matures. Physiol Rev 78: 547-581.
48. Tamagawa T, Oi S, Ishiwata I, Ishikawa H, Nakamura Y, (2007) Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro. Hum Cell 20: 77-84.